# Pilot Study of the Contribution of Fractional Exhaled Nitric Oxide as a Prognostic Marker of Response to Anti-PD-L1 Immunotherapy in Non-small Cell Lung Cancer

> **NCT05985330** · — · RECRUITING · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 56 (estimated)

## Conditions studied

- Metastatic Non-small Cell Lung Cancer

## Interventions

- **OTHER:** Measurement of FeNO

## Key facts

- **NCT ID:** NCT05985330
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-26
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2025-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05985330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05985330, "Pilot Study of the Contribution of Fractional Exhaled Nitric Oxide as a Prognostic Marker of Response to Anti-PD-L1 Immunotherapy in Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05985330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*